Physiological Study to Assess Mechanism of Action of MOBIDERM® in Lower-limb Lymphedema Patients

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

June 23, 2022

Study Completion Date

June 23, 2022

Conditions
Lymphedema of LegLymphedema CongenitalLymphedema PrimaryLymphedema, Secondary
Interventions
DEVICE

MOBIDERM® autofit : auto-adjustable compression stocking

"The experimental protocol will require 2 visits during usual reduction phase performed at the hospital (5 days of hospitalization).~Visit 1 will be performed the first day of hospitalization and will consist of inclusion visit and some evaluations (lymphoscintigraphy, edema volume, cutaneous characteristics).~Between visit 1 (D1) and visit 2 (D3), patients will wear Mobiderm Autofit continually.~Visit 2 will be performed the third day of hospitalization and will consist of evaluations (lymphoscintigraphy, edema volume, cutaneous characteristics, satisfaction survey)."

Trial Locations (1)

37044

CHRU Tours, Tours

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University Hospital, Tours

OTHER

collaborator

Delta Consultants

UNKNOWN

lead

Thuasne

INDUSTRY